ArticleBMC infectious diseases2024

Mitigating the risks of post-acute sequelae of SARS-CoV-2 infection (PASC) with intranasal chlorpheniramine: perspectives from the ACCROS studies.

Fernando Valerio-Pascua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.